← Leaderboards
Kytai Truong Nguyen
Rice University
$5,293,396
Attributed
$9,123,024
Total exposure
8
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $998.5K · FY2006–25$1M$750K$500K$250K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,123,024 · 8
By mechanism
R01$3,683,217 · 2
U01$3,235,427 · 1
T32$1,107,184 · 1
R15$653,882 · 2
R21$377,566 · 1
F32$65,748 · 1
Top collaborators
- Jian Yang6 shared
- Connie C. W. Hsia5 shared
- Ralph P Mason5 shared
- Su Yan4 shared
- Li Liu1 shared
Others in their field
Top investigators on “Nanotechnology”
- Leonard Freedman · Leidos Biomedical Research, Inc.$272,311,477
- David Heimbrook · Leidos Biomedical Research, Inc.$109,987,192
- Roger T Howe · University Of California-Berkeley$94,508,396
- Lynn Briscoe · Leidos Biomedical Research, Inc.$93,294,869
- Daniel C Ralph · Cornell University$90,979,534
- Leonard Freedmand · Leidos Biomedical Research, Inc.$64,603,040
Research focus
NanotechnologyIn VitroNanoparticleIn VivoPolymersCellsArteriesPharmaceutical PreparationsBlood VesselsAnimal ModelInnovationSitePreventEndotheliumPropertyVascular DiseasesResearch Project GrantsPhysiologicalGrowth FactorRattusTissue EngineeringCardiovascular DiseasesInflammationCell Proliferation
Grant awards (27)
Novel nanoparticles to stimulate therapeutic angiogenesis in peripheral arterial disease$522,798
R01 · FY2025 · HL · contact PI
Novel nanoparticles to stimulate therapeutic angiogenesis in peripheral arterial disease$512,342
R01 · FY2024 · HL · contact PI
Novel nanoparticles to stimulate therapeutic angiogenesis in peripheral arterial disease$59,904
R01 · FY2024 · HL · contact PI
Novel nanoparticles to stimulate therapeutic angiogenesis in peripheral arterial disease$530,332
R01 · FY2023 · HL · contact PI
Novel nanoparticles to stimulate therapeutic angiogenesis in peripheral arterial disease$59,714
R01 · FY2023 · HL · contact PI
Novel nanoparticles to stimulate therapeutic angiogenesis in peripheral arterial disease$536,747
R01 · FY2022 · HL · contact PI
Synergistic Upregulation of EpoR /RopE NPs for Enhancing Effective Angiogenesis to treat PAD$442,549
R15 · FY2021 · HL · contact PI
Interdisciplinary Training in Nanotechnology for Cardiovascular and Lung Diseases in North Texas$248,534
T32 · FY2021 · HL · contact PI
Interdisciplinary Training in Nanotechnology for Cardiovascular and Lung Diseases in North Texas$249,472
T32 · FY2020 · HL · contact PI
Interdisciplinary Training in Nanotechnology for Cardiovascular and Lung Diseases in North Texas$246,206
T32 · FY2019 · HL · contact PI
Interdisciplinary Training in Nanotechnology for Cardiovascular and Lung Diseases in North Texas$243,018
T32 · FY2018 · HL · contact PI
Novel Engineered Particle Platform for Endothelium Regeneration$395,497
R01 · FY2017 · HL · contact PI
Interdisciplinary Training in Nanotechnology for Cardiovascular and Lung Diseases in North Texas$119,954
T32 · FY2017 · HL · contact PI
Nanoparticle Drug Delivery in Post-Pneumonectomy Compensatory Lung Growth$639,273
U01 · FY2016 · HL
Novel Engineered Particle Platform for Endothelium Regeneration$346,194
R01 · FY2016 · HL · contact PI
Nanoparticle Drug Delivery in Post-Pneumonectomy Compensatory Lung Growth$632,559
U01 · FY2015 · HL
Novel Engineered Particle Platform for Endothelium Regeneration$365,926
R01 · FY2015 · HL · contact PI
Nanoparticle Drug Delivery in Post-Pneumonectomy Compensatory Lung Growth$625,919
U01 · FY2014 · HL
Novel Engineered Particle Platform for Endothelium Regeneration$353,763
R01 · FY2014 · HL · contact PI
Nanoparticle Drug Delivery in Post-Pneumonectomy Compensatory Lung Growth$647,625
U01 · FY2013 · HL
Nanoparticle Drug Delivery in Post-Pneumonectomy Compensatory Lung Growth$690,051
U01 · FY2012 · HL
Nanoparticles for targeting drug delivery to the injured vascular wall$176,200
R21 · FY2009 · HL · contact PI
Nanoparticles for targeting drug delivery to the injured vascular wall$25,166
R21 · FY2009 · HL · contact PI
Nanoparticles for targeting drug delivery to the injured vascular wall$176,200
R21 · FY2008 · HL · contact PI
Enhanced endothelialization for tissue engineering$211,333
R15 · FY2006 · HL · contact PI
TISSUE ENGINEERED VASCULAR GRAFTS$34,832
F32 · FY2001 · HL
TISSUE ENGINEERED VASCULAR GRAFTS$30,916
F32 · FY2000 · HL